New Inhibitors in the Ageing Population: A retrospective, observational, cohort study of new inhibitors in older people with haemophilia

CONCLUSION: Our data do not identify a second peak of inhibitor development in older patients with haemophilia. Prophylaxis may be beneficial in older patients with severe, and possibly moderate HA, to retain a tolerant state at higher age.PMID:34507368 | DOI:10.1055/a-1642-4067

Source: Thrombosis and Haemostasis - September 10, 2021 Category: Hematology Authors: Jan Astermark Cihan Ay Manuela Carvalho Roseline D'Oiron Philippe De Moerloose Gerard Dolan Pierre Fontana Cedric Hermans P ål Andre Holme Olga Katsarou Gili Kenet Robert Klamroth Maria Elisa Elisa Mancuso Natascha Marquardt Ramiro N úñez Ingrid Pabing Source Type: research